Friday, June 4, 2010

Sexually Transmitted Diseases Screening; Scientists at School of Public Health target sexually transmitted diseases screening

Sexually Transmitted Diseases Screening; Scientists at School of Public Health target sexually transmitted diseases screening

Anonymous. Medical Letter on the CDC & FDA. Atlanta: May 2, 2010. pg. 88

Abstract (Summary)

United States, Sexually Transmitted Diseases Screening, Chlamydia Trachomatis, Gonorrhea, Gynecology, AIDS/HIV, Infectious Disease, Opportunistic Infections, Public Health, Regulatory Actions, Sexually Transmitted Diseases, Syphilis, Trichomonas Vaginitis, Trichomoniasis, Women's Health's.

Full Text

(430 words)
(c)Copyright 2010, Medical Letter on the CDC & FDA via NewsRx.com

2010 MAY 2 - ( NewsRx.com) -- A report, 'Establishment of an HIV/sexually transmitted disease programme and prevalence of infection among incarcerated men in Jamaica,' is newly published data in International Journal of STD & AIDS (see also Sexually Transmitted Diseases Screening). "The goal of this study is to describe the establishment of an HIV testing and treatment programme in the Jamaican correctional system and to estimate the prevalence of HIV/sexually transmitted disease (STD) among adult incarcerated men in this country. A demonstration project was implemented by the Jamaican Department of Correctional Services and Ministry of Health in the nation's largest correctional centre," scientists writing in the International Journal of STD & AIDS report.

"All inmates were offered HIV and syphilis testing, and a subset was offered chlamydia, gonorrhoea and trichomoniasis testing. Cross-sectional data from the project were reviewed to determine the prevalence and correlates of HIV/STD. HIV test acceptance was 63% for voluntary testers (n=1200). The prevalence of HIV was 3.3% (95% confidence interval [CI] 2.33-4.64) (n=1017) and the prevalence syphilis was 0.7% (95% CI 0.29-1.49) (n=967). Among the subset tested (n=396) the prevalence of chlamydia was 2.5% (95% CI 1.22-4.49) and for trichomoniasis it was 1.8% (95% CI 0.01-3.60), but no cases of gonorrhoea were detected (n=396). The prevalence of HIV was significantly higher at 25% (95% CI 13.64-39.60) for persons located in a separate section where individuals labelled as men who have sex with men (MSM) are separated. HIV/STD testing is important and feasible in Jamaica. A special focus should be placed on providing services to inmates labelled as MSM," wrote K. Andrinopoulos and colleagues, School of Public Health.

The researchers concluded: "Other Caribbean nations may also benefit from similar programmes."

Andrinopoulos and colleagues published their study in International Journal of STD & AIDS (Establishment of an HIV/sexually transmitted disease programme and prevalence of infection among incarcerated men in Jamaica. International Journal of STD & AIDS, 2010;21(2):114-9).

Additional information can be obtained by contacting K. Andrinopoulos, Tulane School of Public Health and Tropical Medicine, New Orleans, LA USA.

The publisher of the International Journal of STD & AIDS can be contacted at: Royal Society Medicine Press Ltd., 1 Wimpole Street, London W1G 0AE, England.

Keywords: City:New Orleans, State:LA, Country:United States, Sexually Transmitted Diseases Screening, Chlamydia Trachomatis, Gonorrhea, Gynecology, AIDS/HIV, Infectious Disease, Opportunistic Infections, Public Health, Regulatory Actions, Sexually Transmitted Diseases, Syphilis, Trichomonas Vaginitis, Trichomoniasis, Women's Health's.

This article was prepared by Medical Letter on the CDC & FDA editors from staff and other reports. Copyright 2010, Medical Letter on the CDC & FDA via NewsRx.com.

Indexing (document details)

Subjects:Sexually transmitted diseases--STD, Acquired immune deficiency syndrome--AIDS, Studies, Gonorrhea, Confidence intervals, Mens health, Womens health
Author(s):Anonymous
Document types:Expanded Reporting
Publication title:Medical Letter on the CDC & FDA. Atlanta: May 2, 2010. pg. 88
Source type:Periodical
ISSN:10782907
ProQuest document ID:2014712101
Text Word Count430
Document URL:http://proquest.umi.com/pqdweb?did=2014712101&sid=2&Fmt=3&clientId=45625&RQT=309&VName=PQD

Trichomoniasis; New findings from University of Alabama in the area of trichomoniasis described

c)Copyright 2010, AIDS Weekly via NewsRx.com

2010 MAY 17 - ( NewsRx.com) -- Current study results from the report, 'Treatment of trichomoniasis in pregnancy in sub-Saharan Africa does not appear to be associated with low birth weight or preterm birth,' have been published (see also Trichomoniasis). In this recent article published in the South African Medical Journal Suid-afrikaanse Tydskrif Vir Geneeskunde, scientists in the United States conducted a study "To determine whether treatment of trichomoniasis increases the risk of prematurity. Sub-analysis of a randomised trial."

"We analysed data from HPTN trial of antenatal and intrapartum antibiotics to reduce chorioamnionitis-related perinatal HIV transmission. Pregnant women from four sites in Africa. Gestational age at the time of delivery or mean birth weight. Of 2,428 women-infant pairs included, 428 (18%) had trichomoniasis at enrolment. There were no differences in infant age or birth weight between women with or without trichomoniasis. By randomisation group, there were no differences in gestational age at birth or birth weight. Of the 428 women diagnosed with trichomoniasis, 365 (83%) received antibiotics and 63 (15%) did not. In analysis of actual use of antibiotics, women with trichomoniasis who received no treatment were more likely to deliver a preterm infant when the symphysis-fundal height was used to estimate gestational age (36% v. 23%; p=0.03), but not when the Ballard score was used (16% v. 21%; p=0.41). There were no differences in mean birth weight between groups," wrote E. Stringer and colleagues, University of Alabama.

The researchers concluded: "In pregnant women in sub-Saharan Africa, most of whom were HIV-infected, neither trichomoniasis nor its treatment appears to influence the risk of preterm birth or a low-birth-weight infant."

Stringer and colleagues published their study in South African Medical Journal Suid-afrikaanse Tydskrif Vir Geneeskunde (Treatment of trichomoniasis in pregnancy in sub-Saharan Africa does not appear to be associated with low birth weight or preterm birth. South African Medical Journal Suid-afrikaanse Tydskrif Vir Geneeskunde, 2010;100(1):58-64).

Additional information can be obtained by contacting E. Stringer, University of Alabama at Birmingham, Dept. of Obstetrics and Gynecology, Birmingham, Alabama USA.

The publisher of the South African Medical Journal Suid-afrikaanse Tydskrif Vir Geneeskunde can be contacted at: Med Association S Africa, Med House Central Sq 7430 Pinelands Priv Bag X1, Johannesburg, South Africa.

Keywords: City:Birmingham, State:Alabama, Country:United States, Antibacterial, Antibiotics, Antimicrobial, HIV Infections, HIV/AIDS, Infectious Disease, Primate Lentiviruses, RNA Viruses, Retroviridae, Therapy, Treatment, Trichomonas Vaginitis, Trichomoniasis, Vertebrate Viruses, Viral Sexually Transmitted Diseases.

This article was prepared by AIDS Weekly editors from staff and other reports. Copyright 2010, AIDS Weekly via NewsRx.com.

Indexing (document details)

Author(s):Anonymous
Document types:Expanded Reporting
Publication title:AIDS Weekly. Atlanta: May 17, 2010. pg. 88
Source type:Periodical
ISSN:10691456
ProQuest document ID:2031280491
Text Word Count418
Document URL:http://proquest.umi.com/pqdweb?did=2031280491&sid=2&Fmt=3&clientId=45625&RQT=309&VName=PQD